Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Compugen Ltd (NQ: CGEN ) 1.860 -0.010 (-0.53%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 168,863 Open 1.850 Bid (Size) 1.850 (8) Ask (Size) 1.860 (9) Prev. Close 1.870 Today's Range 1.800 - 1.888 52wk Range 0.5300 - 3.030 Shares Outstanding 86,433,432 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CGEN Stock Earnings: Compugen Misses EPS, Misses Revenue for Q1 2024 May 20, 2024 CGEN stock results show that Compugen missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace CGEN Stock Earnings: Compugen Misses EPS, Beats Revenue for Q4 2023 March 05, 2024 CGEN stock results show that Compugen missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. Via InvestorPlace Performance YTD -6.77% -6.77% 1 Month -5.10% -5.10% 3 Month -2.11% -2.11% 6 Month -1.59% -1.59% 1 Year +47.62% +47.62% More News Read More Earnings Scheduled For March 5, 2024 March 05, 2024 Via Benzinga Earnings Preview For Compugen March 04, 2024 Via Benzinga 7 Speculative Stocks to Double Your Money THIS Year January 22, 2024 Via InvestorPlace Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge December 19, 2023 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session December 19, 2023 Via Benzinga 5 Analysts Have This to Say About Compugen August 07, 2023 Via Benzinga Compugen Earnings Preview August 04, 2023 Via Benzinga Expert Ratings for Compugen May 26, 2023 Via Benzinga Compugen: Q1 Earnings Insights May 15, 2023 Via Benzinga Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results December 19, 2023 Via Benzinga Topics Stocks Exposures US Equities Compugen Ltd. (NASDAQ: CGEN) is One of Tuesday Morning’s Most Active Stocks December 19, 2023 Via Investor Brand Network Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today? December 19, 2023 Via Benzinga Why Are Stocks Up Today? December 19, 2023 Via InvestorPlace Why Is Compugen (CGEN) Stock Up 189% Today? December 19, 2023 Via InvestorPlace US Stocks Higher; Accenture Issues Weak Sales Outlook December 19, 2023 Via Benzinga Topics Stocks Exposures US Equities Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday December 19, 2023 Via InvestorPlace Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program December 19, 2023 From Gilead Sciences, Inc. Via Business Wire 7 Promising Penny Stocks With the Potential to Defy Expectations December 15, 2023 Via InvestorPlace Use Support And Resistance Levels To Avoid Chaos In Your Portfolio October 28, 2023 Via Talk Markets Traders Insights: These Biotech Stocks On Radar: VSTM, SNTX, CGEN, SONN June 05, 2023 Via AB Newswire Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank March 11, 2023 Via Benzinga Why Compugen Shares Are Up Today February 28, 2023 Via The Motley Fool Earnings Scheduled For February 27, 2023 February 27, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
